BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2373871)

  • 1. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
    Lee HH; Weiss SH; Brown LS; Mildvan D; Shorty V; Saravolatz L; Chu A; Ginzburg HM; Markowitz N; Des Jarlais DC
    J Infect Dis; 1990 Aug; 162(2):347-52. PubMed ID: 2373871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
    J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users.
    Cantor KP; Weiss SH; Goedert JJ; Battjes RJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):460-7. PubMed ID: 2016683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
    Khabbaz RF; Douglas JM; Judson FN; Spiegel RA; St Louis ME; Whittington W; Hartley TM; Lairmore M; Kaplan JE
    J Infect Dis; 1990 Jul; 162(1):241-4. PubMed ID: 2192006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE; Hershow R; Kalish LA; Hardy WD; Zuckerman E; Levine A; Delapenha R; DeHovitz J; Greenblatt RM; Anastos K
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):513-8. PubMed ID: 9859966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral coinfections at a New Orleans HIV outpatient clinic.
    Bessinger R; Beilke M; Kissinger P; Jarrott C; Tabak OF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):67-71. PubMed ID: 8989213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
    J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department.
    Kelen GD; DiGiovanna TA; Lofy L; Junkins E; Stein A; Sivertson KT; Lairmore M; Quinn TC
    Ann Intern Med; 1990 Sep; 113(5):368-72. PubMed ID: 2382919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
    Moreira ED; Ribeiro TT; Swanson P; Sampaio Filho C; Melo A; Brites C; Badaró R; Toedter G; Lee H; Harrington W
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):959-63. PubMed ID: 8315579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
    Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D
    Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.
    Guimarães ML; Bastos FI; Telles PR; Galvão-Castro B; Diaz RS; Bongertz V; Morgado MG
    J Clin Virol; 2001 May; 21(2):143-51. PubMed ID: 11378495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group.
    Henrard DR; Soriano V; Robertson E; Gutierrez M; Stephens J; Dronda F; Miles F; Pujol E; Buytendorp M; Castro A
    J Clin Microbiol; 1995 Jul; 33(7):1735-8. PubMed ID: 7665638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-cell lymphotropic virus 1/2 and human immunodeficiency virus antibodies identification among transactional sex workers and drug users in the Dominican Republic.
    Paulino-Ramirez R; Tapia L; Ruiz-Matuk C; Charow R; Budhwani H; Routy JP
    Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):293-297. PubMed ID: 30892643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.